Allergy and Immunology · New Hyde Park, NY
NPI
1780679001
Since 2005
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1 Hollow Ln, Suite 110
New Hyde Park, NY, 11042
Phone (516) 365-6666
Groups this clinician bills Medicare through
Medicare paid, 2024
$946K
42,196 services
Medicare patients, 2024
912
Average age 74
Drug cost, 2024
$945K
3,200 prescriptions
Company payments, 2025
$4,893
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul B Lang was code J2357 (injection, omalizumab, 5 mg), 11,416 times for 27 patients. In total Paul B Lang billed 42,196 services in 42 codes, and Medicare paid $946K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-01-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2357 Injection, omalizumab, 5 mg | Office | 11,416 | 27 | $29.89 | $341K |
| 95165 Treatment - Miscellaneous | Office | 11,123 | 286 | $13.00 | $145K |
| 95044 Test - Miscellaneous | Office | 8,084 | 80 | $4.75 | $38K |
| 95117 Treatment - Miscellaneous | Office | 3,408 | 291 | $11.20 | $38K |
| 95004 Test - Miscellaneous | Office | 2,775 | 122 | $3.43 | $9,529 |
| 99213 Office E&M - Established | Office | 2,012 | 737 | $77.59 | $156K |
| 94010 Pulmonary Function Testing | Office | 377 | 250 | $24.40 | $9,200 |
| 96372 Injection Administration | Office | 307 | 65 | $12.68 | $3,894 |
| 96401 Chemotherapy Administration | Office | 244 | 36 | $67.33 | $16K |
| 36415 Venipuncture Blood Collection | Office | 239 | 206 | $8.62 | $2,060 |
| 99214 Office E&M - Established | Office | 215 | 163 | $109.92 | $24K |
| 99203 Office E&M - New | Office | 144 | 144 | $94.19 | $14K |
| 95115 Treatment - Miscellaneous | Office | 137 | 26 | $9.30 | $1,275 |
| 95018 Test - Miscellaneous | Office | 133 | 12 | $18.43 | $2,452 |
| 99442 Telephone Services | Office | 131 | 95 | $72.05 | $9,439 |
By year: 2022 $1.0M for 42,888 services; 2023 $957K for 42,543 services; 2024 $946K for 42,196 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 239 | 206 | $8.62 | $2,060 |
| 87880 Immunoassay | 14 | 11 | $16.20 | $227 |
Medicare prescription drug claims, 2024
In 2024, the drug Paul B Lang prescribed most often to Medicare patients was Montelukast Sodium, with 550 prescriptions and refills. In total Paul B Lang wrote 3,200 Medicare prescriptions that cost $945K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 550 | 1,510 | 196 | $7,342 |
| Cefdinir Generic | 192 | 192 | 147 | $3,369 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 181 | 213 | 106 | $5,729 |
| Ipratropium Bromide Generic | 179 | 316 | 97 | $5,356 |
| Fluticasone Propionate Generic | 144 | 297 | 77 | $3,430 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 138 | 292 | 46 | $185K |
| Azelastine Hcl Generic | 131 | 249 | 55 | $3,546 |
| Prednisone Generic | 130 | 132 | 93 | $379 |
| Azithromycin Generic | 127 | 147 | 93 | $984 |
| Levocetirizine Dihydrochloride Generic | 91 | 251 | 35 | $1,134 |
| Mupirocin Generic | 82 | 89 | 65 | $659 |
| Breo Ellipta Fluticasone/Vilanterol | 79 | 157 | 20 | $61K |
| Doxycycline Monohydrate Generic | 69 | 69 | 52 | $806 |
| Famotidine Generic | 55 | 92 | 25 | $603 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 53 | 93 | 26 | $55K |
Brand drugs: - claims; generic drugs: 2,313 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul B Lang $4,893 ($4,893 in general payments such as food, travel and fees) from 22 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $1,020.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 28 | $1,020 |
| AstraZeneca Pharmaceuticals LP AZN | 20 | $662 |
| GlaxoSmithKline, LLC. GSK | 31 | $535 |
| Genzyme Corporation SNY | 16 | $527 |
| Pfizer Inc. PFE | 18 | $399 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 13 | $278 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 7 | $182 |
| Insmed, Inc. INSM | 6 | $174 |
| Genentech USA, Inc. ROG.SW | 7 | $162 |
| Amgen Inc. AMGN | 7 | $153 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.